scispace - formally typeset
M

Myron S. Cohen

Researcher at University of North Carolina at Chapel Hill

Publications -  576
Citations -  50913

Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.

Papers
More filters
Journal ArticleDOI

Partner notification uptake for sexually transmitted infections in China: a systematic literature review

TL;DR: PN programmes are feasible in China, particularly among men who have sex with men and other high-risk groups, and further research on STI PN, is an important public health priority.
Journal ArticleDOI

Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation.

TL;DR: Given the public health impact of trichomoniasis, this study recommends using any 1 of 3 predictors to identify women who would benefit from targeted culture for T. vaginalis detection.
Journal ArticleDOI

Comparison of molecular and microscopic techniques for detection of Treponema pallidum in genital ulcers.

TL;DR: The ability of direct immunofluorescent staining (DFA) and the PCR to detect Treponema pallidum in specimens from patients with genital ulcer disease is compared to suggest that DFA and PCR are equivalent methods for detection of T. pallidums in genital lesions.
Journal ArticleDOI

Pyogenic otorhinologic infections in acquired immune deficiency syndrome.

TL;DR: Surgical drainage proved to be the only effective means of controlling his otorhinologic infections and is recommended for this type of patient when standard antibiotic therapy for sinusitis and otitis media proves ineffective.
Journal ArticleDOI

Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi.

TL;DR: The protease (PR) and reverse transcriptase (RT) regions of HIV-1 isolates from 21 antiretroviral (ARV)-naive Malawian adults were sequenced and analyzed to determine the prevalence of drug resistance-associated mutations in this population.